taxifolin and Atherogenesis

taxifolin has been researched along with Atherogenesis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chai, X; Fan, G; Feng, Y; Gao, X; He, S; Karas, RH; Liu, H; Lu, Q; Orang-Ojong, B; Pan, L; Song, YS; Wang, T; Wu, H; Zhang, P; Zhang, Z; Zhu, Y1
Appazov, NO; Arutyunyan, TV; Ibadullayeva, SZh; Korystov, YN; Korystova, AF; Kublik, LN; Levitman, MKh; Narmanova, RA; Shaposhnikova, VV1
Arutyunyan, TV; Korystov, YN; Korystova, AF; Kublik, LN; Levitman, MKh; Shaposhnikova, VV1

Other Studies

3 other study(ies) available for taxifolin and Atherogenesis

ArticleYear
Selected Phytoestrogens Distinguish Roles of ERĪ± Transactivation and Ligand Binding for Anti-Inflammatory Activity.
    Endocrinology, 2018, 09-01, Volume: 159, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Atherosclerosis; Cell Line; Curcumin; Endothelial Cells; Estrogen Receptor alpha; Humans; Inflammation; Interleukin-1beta; Ligands; Lipopolysaccharides; Lipoproteins, LDL; MAP Kinase Kinase 4; Molecular Docking Simulation; Mutation; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phytoestrogens; Protein Transport; Quercetin; Response Elements; Signal Transduction; Silymarin; Tumor Necrosis Factor-alpha

2018
Camel thorn extract reduces activity of angiotensin-converting enzyme in rat aorta increased during aging and treatment with NO-synthase inhibitor.
    Bulletin of experimental biology and medicine, 2014, Volume: 158, Issue:2

    Topics: Aging; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Atherosclerosis; Flavanones; Glycosides; Male; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Plant Extracts; Quercetin; Rats; Rats, Wistar

2014
Effects of taxifolin on the activity of angiotensin-converting enzyme and reactive oxygen and nitrogen species in the aorta of aging rats and rats treated with the nitric oxide synthase inhibitor and dexamethasone.
    Age (Dordrecht, Netherlands), 2013, Volume: 35, Issue:6

    Topics: Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Atherosclerosis; Dexamethasone; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Glucocorticoids; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitrogen; Peptidyl-Dipeptidase A; Quercetin; Rats; Rats, Wistar; Reactive Oxygen Species

2013